Pancreas Summary  by unknown
EDITORIAL
At each of the World Congresses, three members of the Scientific Programme Committee are asked
to review and summarize the meeting in the three major topic areas of pancreas, biliary and liver. At
the Washington World Congress (May 2004), the honour for summarizing the pancreas and biliary
presentations fell to Professor Roland Andersson of Lund, Sweden, and Dr Lilian Kow of Adelaide,
Australia, who respectively reviewed the pancreas and biliary presentations.
As a prelude to this issue ofHPBwhich highlights the pancreas and biliary scientific work presented at
the Washington World Congress, their respective summaries are included below.
I thank Roland and Lilian for their superb contribution, as I thank all of those who submitted their
work for publication in HPB – I present to you in this issue of HPB the best of the best in the pancreas




The pancreas sessions during the 6th World Congress
of the IHPBA in Washington were well attended and
covered many of the questions and controversies that
exist in pancreatology. Free papers and posters,
symposia, updates, debates and keynote lectures
covered acute and chronic pancreatitis as well as topics
related to pancreatic tumours.
In the symposia the following topics were
discussed.
Necrotizing pancreatitis. The ideal marker for
severity assessment does not exist. However, scoring
with APACHE II is probably the best overall and
C-reactive protein (CRP) determination the best
single marker. Computed tomography (CT) is a late
denominator. The dynamics of multiple organ dys-
function are important. Enteral nutrition is feasible,
probably of benefit and could potentially be adminis-
tered nasogastrically. The value of various supple-
ments is still to be proven. Surgery should be
performed on proper indications and timing (late) and
minimal invasive methods are under development.
Intraductal papillary mucinous tumours and
mucinous cystic neoplasms of the pancreas are
different entities and premalignant with potential
progression to invasive cancer. Resection should be
tailored according to pathology with an attempt to
preserve function. First-line lymph nodes should be
resected.
Pancreatic tumours were discussed and an algo-
rithm for staging including CT, potentially endoscopic
ultrasound and laparoscopy was presented. Vascular
resection is feasible and could be justified in resection
with radical attempt. Extended pancreaticoduode-
nectomy could not be indicated, while extended lymph
node “sampling” could potentially be of value for
tailoring future adjuvant chemotherapy.
Free papers and posters on acute pancreatitis high-
lighted the following.
Disturbances in microcirculation and concomitant
ischaemia and reperfusion injury represent central
mechanisms, where blocking of galanin, a vasoactive
neuropeptide, as well as the use of hypertonic saline
solution, was effective (1346, 1347, 1354). Gut barrier
failure and translocation of bacteria decreased by the
use of the tumour necrosis factor (TNF) inhibitor
pentoxifylline (1352). Antibiotic penetration (piper-
acycline/tazobactam) was effective in the necrotic
pancreas (O203).No increase over time was seen in the
incidence of fungal colonization of necrotizing
pancreatitis despite the use of antibiotic prophylaxis
(1351).
APACHE II as evaluated after 48 h was better than
Ranson in predicting severity in acute pancreatitis
(209). Necrotizing acute pancreatitis is still associated
with substantial mortality (210, 1353). Endoscopic
sphincterotomy within 48–72 h and laparoscopic
cholecystectomy within 8–10 days were recommended
in acute biliary pancreatitis (1358). The overall trend is
towards more conservative management (1353, 1355);
complications following necrosectomy are still
frequent and potentially life-threatening (1349).
Future treatment may include immunomodulation
and several experimental studies demonstrated the
benefits of, for example, inhibition of NFkB (202),
antioxidants (204), or EPA (omega-3 fatty acids),
resulting in a down-regulation of the inflammatory
response and a decrease in both pancreatic and
pulmonary injury.
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In chronic pancreatitis, free papers and posters
discussed the following topics.
Several surgical approaches but no randomized
comparisons. Saving parenchyma (pancreatic head)
preserved exocrine and endocrine function without
decreasing pain relief (207, 1363). A previous
lateral pancreaticojejunostomy increased perioperative
complications following concomitant pancreatico-
duodenectomy (85). Duodenum-preserving pancreas
head resection is a safe procedure, reducing pain and
was reported to preserve endocrine function (5, 208)
and when combined with a Partington-Rochelle duct
drainage rendered pain relief in patients with chronic
pancreatitis and multiple duct stenosis (205).
For pancreatic tumours, free papers and posters
highlights included the following.
Several factors for invasiveness and prognosis were
described. Urokinase-type plasminogen activator
overexpression correlated with pancreatic cancer
progression and invasiveness (38). The mammalian
target of rapamycin (mTOR) is up-regulated in
pancreatic cancer and inhibition potentiates the effect
of chemotherapy (40). Moderate to high expression
of interferon-alpha/-beta-receptor chain-2 in pancrea-
tic cancer correlates with improved survival (42).
High expression of vascular endothelial growth
factor correlates with lymph node metastases and
impaired survival (43). A potential correlation between
pancreatic cancer and smoking was implied as
methylantracenes (polycyclic aromatic hydrocarbons)
were suggested as a potential aetiological agent (87).
The use of EPA, i.e. omega-3 fatty acids, could
represent an agent for obtaining pancreatic cancer
proliferative arrest (44).
For diagnosis and resectability determination,
endoscopic ultrasound (EUS) less efficiently predicts
nodal status and final margin status but may rule out
portal vein involvement. EUS-guided fine-needle
aspiration is highly accurate (39, 45, 126, 139).
Computed tomography in general renders reliable
information on staging (1326, 1329). Contrast-
enhanced ultrasonography could be a future tool for
the differentiation of pancreatic cancer vs pancreatitis
(1438). Tumour markers (CA 19-9) are only useful as
adjuncts to other diagnostic modalities (1373). Diag-
nostic laparoscopy reveal metastases in 6.4% of cases
prior to pancreaticoduodenectomy, thereby implying a
selective use of this modality (91).
The positive correlation between high volumes of
pancreatic surgery and low operative mortality was
demonstrated (1391) and a survey among Canadian
surgeons expressed support for regionalization of
major HPB surgery to high volume centres (1322).
Neo-adjuvant preoperative chemoradiotherapy in
locally advanced pancreatic cancer, also in patients
with suspicion of vascular involvement, rendered
selected patients resectable (86, 1421, 1435) and the
histopathological response to chemoradiotherapy
correlated with survival (1422). An important Japanese
multicentre study on the extent of pancreatic resection
demonstrated that extended lymph node dissection in
pancreaticoduodenectomy did not improve survival
(6). For neuroendocrine pancreatic tumours long-term
results are to be considered good (88, 1430). Several
abstracts reported the use of a duct-to-mucosa
pancreatic anastomosis (1401–1405). Portal vein
resection may be carried out, but when reviewing the
literature up to 2002 the survival benefit was still to be
shown (127). Actual data presented at the meeting
demonstrated that portal vein resection is possible
(1497) and vascular reconstruction is justifiable,
although increased morbidity and mortality were seen
following combined arterial and venous reconstruction
(41). Laparoscopic surgery is safe for primarily benign
lesions (123, 1387) and potentially for neuroendocrine
tumours (125).
Cystic lesions were addressed by several authors,
and for symptomatic pseudocysts, treatment options
included endoscopic, percutaneous or surgical
approaches, although surgical treatment still seems
effective (1368, 1388). A preoperative accurate diag-
nosis of cystic tumours is frequently possible (1424)
and for intraductal papillary mucinous tumour
(IPMT), preoperative EUS is useful (1425), as is
intraoperative frozen section (247). IPMT has a
malignant potential and if invasive has a less favourable
outcome (1441). A tumour size above 30 mm, mural
nodal size 45 mm, and CEA 4110 ng/ml in
pancreatic juice were suggested as predictive of
malignant IPMT (1452).
The risk of postoperative pancreatic fistula corre-
lated with pancreatic consistency, the use of invagi-
nated anastomosis and closed suction drainage (129,
1402). The complication risk was reduced by using a
separate Roux-en-Y pancreatic anastomosis with
external pancreatic duct diversion (1393) or when
using the round ligament and fibrin sealant for rein-
forcement of the pancreatic anastomosis (1380).
Pancreatic fistula is still frequent after pancreatectomy
despite mechanical closure (130). The incidence is
decreased by stapling the stump and adding a covering
jejunal loop as compared with stapling and ligation of
the main pancreatic duct alone (1384). Massive post-
operative haemorrhage after pancreaticoduode-
nectomy increased following preoperative
chemoradiotherapy (1396), extended pancreatico-
duodenectomy or anastomotic leakage (1409).
Complications in general correlated with the use of
preoperative biliary drainage and the existence of
positive bile duct cultures (122, 1366). Palliative
laparoscopic gastric and biliary bypass was associated
with a rapid recovery (89, 140).
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